University of Nebraska Medical Center

DigitalCommons@UNMC
MD Theses

Special Collections

5-1-1942

Haematological mode of action of the sulfonamide drugs
Hubert H. Paulson
University of Nebraska Medical Center

This manuscript is historical in nature and may not reflect current medical research and
practice. Search PubMed for current research.

Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses
Part of the Medical Education Commons

Recommended Citation
Paulson, Hubert H., "Haematological mode of action of the sulfonamide drugs" (1942). MD Theses. 943.
https://digitalcommons.unmc.edu/mdtheses/943

This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It
has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For
more information, please contact digitalcommons@unmc.edu.

'---- .·

�TO.LOGICAL MOD1 OF ACTION
OF TH1!.. Slf"LFONAMID£ DRUGS

L

H.

o.

PAULSON

SENIOR THE.SIS
Presented to the College of Medicine,

University of NeQraska,
1942

-I-

The advent of the sulfonamide drugs has opened up a new
phase of ther,apy in the field of medicine. At first, all

or

the

work on the eff'ectivenbss of t.nese drugs was done on the emplrioal
be.sis. Some o£ tne later work has attempted to find the mechanism

•

of the drug's action on bacteria.,. It is the purpose of this
paper to review the liter�ture, to bring together the v&rious
findings, am to attempt .e. correlation.

or

The scope o£ this paper is int.ended to cover only the mode
action

in

the blood stream. Local applications, urinary tr&ct

use, and large concentrations in vitro have a siightly dif'feren�
action than in vivo action, and .are, therei'ore, avoided a.s much
as possible in this writing'.. -As deemed necessary, in vitro
exjl6riments will be ret'erred to for the purpose of explaining
the in vivo mechanism.,.
For the sake of simplieity, the paper shall not go into tbe

detail of proving sulfanil�mide the active principal o£ prontoail,
and shal1 de&.l with this as an accepted fact.
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Ir.'TRODUCTION
Chemotheravy, the brain-child of Erhlich in l.904, has recently
.added ,another member to its .family., This ird.'ant, the sulfonaii1ide
drugs, is expt,riencing a very r&:pid rate of growth ., How large
will. be tne .final field. of' applications can only be postu.Lated at
the present time.
The birth of the drug took place in 1909 when Domagk, a
German scientist, fowxl that an azo textile dye, which had been
synthesized by Gel.mo in 1908, was therapeutic against mouse
septicemia� This knowledge was lightly regarded, and le.ft to
slumber for many years.

In 1935, i,detzch .and Kl.arer took out a

German patent for a brick-red dye which 1ate,r became known as
"'Prontosil;•. They f oum this to

be

slightly toxic to animals,

but did no further work on the dye ...
It wiis in the later pa.rt of 1935 that Domagk unsa.rthed his

V
'.

ear.lier ax.pt:irimant •nd started his investigations with l'rontosil..
His rtisu.lts

or

nine months work were published in 1956, where h�

stated that prontosil, a relatively non-toxic reu dye, when givan
by mouth in sm.al1 doses, prevented the evolution of' otherwise

t:atal hanolytic streptococcal infection in miceJ controlled am
cured chronic streptococcal infection in rabbits, and t.avor�blf
influenced the course

or

staphylococcal infections in r.abbitsJ

but that the drug n.a without effect in the treatment of certain
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pneumococcal and other experimental infections 11 (B-5). The data
of the experiments is as follows: Twelve mice were given a single
oral administration of prontosil of' 0.,.02 to 10 mgm. The Eice
were injected intrap,&ritoneally with 10 M.L.D. of ha>.molytic
streptococci.,. Smears of' the peritoneal content of the control
mice snowed large numbers of cocci as well as degenerating whit�
blood ct1ils.

Smears .from the treated animals showed no cocci or

damaged ce�ls, but only

&

.few leukocytes, monocytes, or lympho

cytes, � these appeared to be in good condition (B-7).
Since this startling report, workers in France, EnglallQ.,
Germany, and t:ne United States have led the field of investip,tion..
. .'-..___,

Many ,of these workers have advanced theories to explain the
mechanism of the bacteriostatic action of the sulfonamide druga..(
These will. be taken up individWill.y latiir in the paper.

.��-�.,.:'�-�•;·;i1

:-.- '-�'
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GENER.AL: OBSERV:!T IONS
Tho laboratory investig.ations and the specific theories as
to the mechanism of the -action of the drug have their bases on
the c1inical -arii laboratory investig&.tions occurring shortly
.tter the -advent

or

Domagk' s announcement.,

These miscellaneous

observ.ations will be reviewed so as to .act as .a background for
the specific theories, :a.nd to help correla.te these theories.
The or1gi.n8.l experiment of Domagk was the use of •o.3 cc r4
& l:10,000 dilution ot. ;a cu:l.t\ll.'8 o these organisms (bamolyti.c ·
f

streµtococcus), representing 10 M.,,L ..n .. • which was �ected into·
the peritoneal ca•ity of . mice.. •one :and one-hall' h<>u.1-s .d\ar

dt ·

infection, certain ot theae mice were t:i:·ea� or.a,lly with. d.of�S ..

Prontosil varying from 0..2 cc of• 0.-01 per cent aolu\ion to lA •41�·.
ot .al per cent watery suspe�ion of the drug.

The treat¢ mica

.all survived seven days (the duration of the experiment.),

wldle

the untreated controls ,all, died by the f'ourth day ot i;he infeo� ·
(B-3). Thus, it was shown that the sulfonamide d.ruc w.s

e&.J*o.lt,

of protecting the uimal from the f'atal effects of the halolytio
streptococ-cus.. This experiment was otten repeated in

nwnerolll 1

but now insignificant, investig�tions performed on the Continent.,_

am

the results varif'ied the findings of Domagk.

.

.-

}_.. :,,

By plot.ting the growth curve or his experiment ap.:i:ii�'\i,;
.sta:nc:h.rd growth eui'fi wt the bamol.ytic streptococci .aa set
forth by Zinsser, Marshall. found the following res

.: . - .. '.,.,�> - ::�. ..., ... ·-.,·.

t (B-1h

·£,

·�

".;_��;

; .. ·.-..
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Thus it is shown that, al.though the drug has a very marked .at.fact
on. tba growth curve, there is• lag period o£ several hours before
the dist&vor.a.b.l.e effect ls .wanit'ested. ..After performing sevei·al.
experiments on the growth curve, Spring came to this conclusion,
•The principal feature exhibited in all the growth curves was
tb&t multiplication of the bacteria in the presence ot sulf'a
pyridi?l8 W&S esseutia.1 before any bacteriostatic or bactericidal.
.action

or

the drug became evident• (74). His observations were;

•The various growth curves indicate that, under the conditions
ot these experiments, growth of pneumococci occurred in the
presence ot concentrations of sulf'apyridine up to 10 mgm. per
100 co .. in the same manner .as the control media containing no

I
I

I
J
!1

LI

:�

-5-

sul.f',apyridine, for an initial period of 4 hours or longer .,

During this early veriod there w-as usually no appreciable lag
phase alXi the same logarithmic rate of growth occurred with
sulf'apyridine as without it .. The growth phase was usu.ally
f'ollo,red by• phase of' stationary growth and then a period or
maximum su.lfapyridine effect• (74)., Clinical observations
substantiate this observations where it bas been noted that the
drop in a feb*ile temperature and clinical improvement of the
pe.tient does not take place until after a varying period, on
the .average ot £our to six hours.
Why does not the effect become manifest immediately?
Mellon puts :forth the answer when he �ys,

11

sulfani1amide 1 -as

it .is f'ashio.ned. in the l.a.boratory oi' the chemist, is as harmless
to bacteria .as sugar of milk were it not for the c&pacity that
it posse6ses to be oxidized to the •activated'ff form by the
bacteria themsel.ves.. Thus their growth is impeded, or as we
say, bacteriosuitic. Obviousl.y, it means that the awerobio
infection would not be so likely to be overcome as rerobic ones w
(56), Discussion of his idea will be presented in a later section,
The next question to come up is just what is it that is
happening to the bacteria to show a decrease in the �ate o£ the
growth-curve .. Ball.enger .and his co-workers state, •When sulf',anil,
c&mide is diluted as much as it is in tbe bl.ood stream, in vitro
it &p:peers to act as • bacteriostatic rather than

as

&'

bacteri

cidal •gent, The investigations .... .., •• imioate that sulf'-anW.m:We

-6-

acts in vivo by bringing about a change in the susceptible
micro-organisms, which permits phagocytosis� (3).

•The results

o£ these in vitro experiments suggest tnat su.lf'anilrunide even in
a concentration as high as 1% is prim&rily bacteristatic and
only indirectly bactericidal toward ha?molytic streptococci of
groups

cA

and D", remarks Neter (61). Bliss found also that there

was no direct bactericid.aJ. action on h.emolytic streptococci (7) ..
Osgocxi says that his experiments show conclusively that even hijh
concentrations oC sulf�.nilam.id@ does not kill the beta hamolytio
streptococci (62). Spink agrees that the primtty action. oC the
drugs is one o£ bacteriostasis, and£ound t�t there is a dimbt.1ti.on o£. the r.ate o£ growth o£ the bacterial cells (B-4}. Bliss

used Welch bacillus &nd £01..UJd that the leukocytes were filled
with ingested organislllS; the animals traated with ault.anilamide
showed s. decrease of' bacilli £ree in the pE;ritoneal exudate
� the leukocytes showed £ewer ingested cells (7}.

He said,

•the only interpretation that can be placed on the ooserved facts
is that sultanilamide inhibited the growth of the bacteria in
vivo tt (7}. · Further experiments by Marshall led him to the
conclusion, •There is othbr evidence to support this general
view of the mi.ture of sull'.ani�mide ba.cteriostasis.

It is the

f'&ct that the process is readily reversible. ..ls any point short
of complete bacterial death the organism will regain £ull

-7-

mediUD1• (B-1)... Schnitker .also came to the conclusion that

action WRS that of bacteriostasis (B-6); arxi so did Keefer (55).
Thus it can readily be seen that the leading investigators of

the drug have univers a.lly come to the conclusion that the

primary action of the drug is that of ba.cteriostasis in the

blood stream ..

The general et'i'ectiveness of suli'aniJ.amide is a consideratlon

of every clinioe1.l. use of the drug .. The general character and

type of infection clinically shows a noticeable influence on th&

efficacy of the medie&tion.. This has been ooncisel.y eiU!lllll8d by
LoQaood thus, flThe clinical aspects of this study showed

stri:k ing differell).ces in the ef'fectiveness of suJ.tani�mide •

These differences were related more to the character

Qt

the leiion

than to the identtty of the bacterial. infection. Sult.a.nil.amide
was moet ei'£ectiv� in bacteremia, l.ymphangitis, erysipel.is, ,and
cellul.itis; it

'A$

highly effective in early· iDfections with

little suppuratio�. It had a questionable eff'ect in searlet

£ever, tonsilliti$, sinusitis, otitis and mastoiditis. The

drug was ineffective when .abscesses were well established,

except perhaps injllmiting their i'urther spread and proteetilli
tissues -against invuion when dr&illa&e aa

tonsillitis bas later �en £own to 'be s�p,-.

tible to sulf'�U.1,;,11- �iM,e, Longco}le (44) conclmea, •tna.t the
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over consider.able periods of time will not always eliminate
hamolytic streptococci rrom persistent and latent infections
of the tonsils:a .,

•The number of badteria and the virulence of

the strain are important :factors in this a�tion.

Experimentally,

the et.t'ect of sult,anj lamide is not evident if large inocul&of
the organism .re usedu • .-In the llUJDan patient ......when the

infection exceeds• certain number of organisms, the ther.apeutic
effects of sulf'-anUamide rapidly diminish, regardless of the

virulence of the strain,* summeriaes Schnitker (B-6).

In their

experiments with p-ontosil and sult;anilam:lde, Long

Bliss

.town that (l.} ciowa of harmol.ytio streptococcus

or

,am

more than

10,000 M ..L.D .. were .t'atal to their mice even though protected
with the drugs, .am, (2), the.� streptococci of l.ow virulence, even

onq one lethal. dose, was £.atal to the mice inspite of the
B

drug protection (-5).,

King states that the ettect varies

im'ersely with the number of bacteria (56) ..

Neter backs up the

in . vivo concl.usions with his in vitro experiments-1' sulf'.aniluwle
in.a concentration of

1%

£.ailed to inhibit visible growth of

the hamol.ytic enterococcus, when undiluted broth culture was
used for inocUlation of the test culture medium•. With smaller
inocula, however, • marked bacterioatatic �t"ect could be
demonstrated,,.� ••These observations on the relationship between
the degree of. bacteriost.atic effectiveness of aulf-anilamide aDd
tbl nuaber oC micrQ-Or��iSllls. used t"or iDocula:�ion �l

those obtained with hanolytic streptococci and other bacter:La"
( 60).,. The above writers have thus shown thb.t there are two
factors which play an important part in the effective action

ot

the drug-(1) the sue pf the inoculum, and (2) the virulence
of the infecting organism. Clinically, the drug is effective
in those infections where the inoculum has not had a chance to
become too large, am in those infections which:are more virulent
and produce more wide-spread infections rather than forming
localized infections,
Th� la.ck of eftioacy in looa.lized infections is the founda
tion

ot

the theory at Lockwood .m his co-investigators, a�. wUJ,

be taken up separately later.
[

- - _\_,/

"'The blood taken immediately af'ter injection (ot s� ·
&mide) has a greatly encha.nced antistreptococcal power .... � . .A
result of this kind izxiicates that the sul.fanilamide acts on the
bacteria. without having to. be changed into some other .active
substance in the bodyt', states Fl.eming (19) ! However I this doea
not ..agree with the £iniings, as mentioned bet ore, by Long and
Bliss. Fleming I s concl.usion f'rom his �.xperiment c&re open to
·questioning bec&use his technic was not exactini .. Keefer
counters with, •we-were unable to demonstr-ate a bactericidal
effect of sulf'.ani1amide when it was .a.dded to plasrns, .althouah·
bacteriostasis wu pz-esent in plasma containing sult&ni�mide.
This ba.cteriostasis was less striking in plasma than it was in
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whole blood� ( 55),, Typical of the blood findings is that of
Henschel�11 the number of guinea pig leukocytes taking up bac�eria
and the number.or bacteria engulfed per leukocyte was marked.ly
increased• (in the presence of sulfa.nil.amide) (27) .. The actual
�feet on phagocytosis will

be

discussed later.

Su.lt·an:U.&wide has been tried on every infection that imagi
nation could deem its worth. It has worked in some diseases, but
not in others. "Virtually all -Of the infections decisively
influenced. are of zrobic nature. Ji.n exception is the st6.phylo
coccus, which, however, is prone to form localized abscesses
even when the infection is generalized" {57) F states Mellon.
By tnis observ.ation he claims that his orlwil.tive-enzymatic
theory is supported; this will be referred to .later. Broh-Kahn

I
t,

.f'ound that the org.,nisms which are affected by su1£an1la.mide
dev�1op better m·obioally; th.it there· is bacteriostasis with the
drug urner £r'obic but not under allall'obic conditions. From this
he concludes that the drug at'fects only a:;robic mechanisms of
nutrition, aoo. that al:lmrobic mechanisms are not .9.ffected (lo}.
The consensus is tnus: the.t the sulfonamide drugs are eftective
in zrobic infections. .Although the drug bas been found to work
in some of the anzrobic infectiollS, each of such observations has
been carried on under conditions where the media were actually
arobic •
.&. number of the 11i-.vitro experiments

..... _. -_ __ .,;,"'

-

'&re

.rathQr miscell&n$ous

-ll-

be reamed
supports for the
maze can
in nature, but f'rom their
.
.
'
various theories which will be breught to attention later. King
has fouai that in tissue culture there is toUl'.li .a decrease in
the size of the colo�, and also a decrease in the size of the
. hmmolytic zone of the hamol.ytic streptococci (56). Lyon hli.s
shown that streptococci grown in media containing sulf'anilamide
became s'W!ceptibl.e to phagocytosis .fUXl .agglutination, but
regain their virulence it tr.ansplanted back to a medium f'ree
al the drug ( 45), flThe t'tilure of par.a...aminobenzenesulf oDDid.•
to exvt-.a bacteriostatic effect upon group D e.nd minute members

or

group G beta bamol.ytic streptoc.occi in vitro is

theoretical ,&Di pr.ctioal importance,,

ot

both

T� resul.ts of the in

vitro tests show that marked bacteriostatic e£tects were obtained
when various str.a.ins belonging to group J., C, .and the larger of
group G

were

tested. The significance

various groups
I

.....

or

or

the variations in the

beta bmmofytic streptococci is not clear,

but it suggests that group D and the minute members o£ group G
hamol.ytic �treptococci ..possess certain chemioal. or metabolic
qualities which d�er .from those of the other groups

ot

hamo

}3tic strei)toeocci•, .found Bliss (8}� From these statfitmenta we
gleu two id•s-(l.) tbat the action of the drug ia on the
bacteria and is reversible, .aDd (2) that there ia what saema to be
• cl:limical (or ensyatic) 'Variation of the b&ctei·i.a which oaus••. ·
.a v.arJation in the ettectiveness of sulf';aniJsrmi.de.

-12-

· "-...--·

Bacteriology;attaches great :importance to the. appean.nce
of the bacteria colonies in the degree
has foUDd, •streptococci

:am

or

virulence. ·Tunnicliff'

pneumococci grown in 1:1000 sulfa.

pyridine plain broth show by chain formation &nd staphylococci
by slight colony change some� dissociation which makes the
organism more pbagocytable than:anequal number in the S phase•.
(76)., "When, to• suspension
'i

or

vi.able bacteria susceptible

to the a
. ction o£ · aultan1 lemide, the drug is -added in sutf'icient
concentr-:ation, the morphology of the bacteria undergoes changes
-.tter seveital houra .......The pieomorphisa illdioates degeneration

inJury

.

of the cell•, is the results of .the work ot Spink (B-4) ..
Baclley town that serial passage of pneU11ococei through sultuil,..

-:anri

.

.

illlide m:-oth lef't s� colonies with their original virule�,

.am

some cbanged from the mucoid to the smooth forms (25)..

He

-also says, •There can be no dissociation without bacterial.
growt-h

:am

multiplioation., Thus .a weak bacterioatasi1, taaintaillllCl

over a sutt'icient period, may f'-avor phase tr.ansf'or•tion, while
·&.

strong bacteriostasis may prevent it• (25). Had.1-y cQUCl\lliea,

· ::.,

•.that the , sGlective' intluence of su.1.tanilamide on the more
virulent mucoid, .and its diminished inf'luence on the less viru:,..
lent &lllOOt,h, might help to explain the greater . observed. thera-1
;"f

:;,eutic eft'ects of this drug in patients experiencing severe
streptococoal inf'ections than w.ben;administered to patients

haviD&

infections ot subs.cute or chronic tY'P9* (25). Th$ -�:

·1
- •:
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f.act in these expressions is that there is a change in the
colonies of the bacteria from the more virulent £orm to the less
virulent form, brought a.bout by the influence ·ot the su.lfanila
mide upon the bacteria .,.
•conceiv.bly, bacteriostasis may come about either-through
the inhibition of the growth energy o£ the organisms, or its
r�direction toward th,e evoiution o£ a leas virulent and more
pbagocytable growth phase•, states Mellon (B-7).

He

goes on

testate that his co...-orker, Locke, •suggests that bacteriostatic
•

c

:action is in some instances .associated with-a trend toward•
emooth or non-virulent phase" This change need not imply a
·reduction in growth energy, except in so tar as it conduces to
I 1,

phaucytosis, which event ul.timately results in an .almost complete
supression of growth" (B-7)" From this, Mellon would seem to
imply that the eff'ect ot the drug on the orsa_nism is not directlg·
on: the phase of the organism, but rather that ther'i'.,; bas taken
J.1.a.ce-a cha:nge which is manif'est in the change in th9 phase�
.

.

.

There a.re two. statements which show the associated factors

in the eff'ioacy of the sulfonamide drugs which do not need

substantiation because

or

their universal .acceptance and approva1

by .all investigators .. Bush states, "In gener.al, the drug ia
more effective the higher its concentration, the higher the
te�ture, the tmaller the number ot organisms, and the poorer
the mediwa• ·(12) ._ Collin suu up his ,article by saying, •that·

-1.4-

the presence of &ntibody ·and sulfanilamide was much more etf'ective
than either of these· ;agents alone. From a practica.l stam.point
in thera.peutics, it has been f'ound that a patient who posnsses
antibody £or .a spec.ific infection derives much more improvement
than: one who bas little or no antibody formation" (15).

Schnitker

is also of the same opinion as:he states, "the body must retain
or .acquire an 1.mmWlity to rid itself of the ;arrested organisms
which .ar-e producing the .disease• (B-6}.
The clinical experience has been SUJ.lllled by Keeter as� 1Tro11
the experimental ,as well. •s t_he cllnical evidenQe so tar we a.re "t
forced to concl.ude that at least two con:iitions are essential
tor� optimum theapeutic .action

or

sult'�ide. The

chemical must be present in suft"icient coneentr�tion to

prCld�•

opti.mwrl. baeteriostasis, &nd the body's ii1id'ense mecbani•m must t<:
.acquize or retain the power to destroy viable organisms• (SS) •
. In &"WIIDiU"f, the main points tbat have been shown here ue:
(1). sw.f'•nilaa:uie prod:uces -a bacte;dosta.tic actl.on on the p-QW'th
of the organisms .Uected; (2) there is a lag in_ the aotionJ
(�) the diseases .af't'ected are those of arobic nature and where
f

the Ol"ganisms ara not 1.o�ed in an .abscesea, and (4) the ef'eats
1"· · .

noticed.bacteriologioally irxiicate that the ettect

u d:1.rect,q

on the bacteria, ii) some way at'feotiDg its metabolism, as shown
by 1;be change in phase -&Di decreased. vii,-ulence.
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JLQTION ON THE BODY DEFbNCES
,Although.it has already been stated that. the action of
sulf'ani.la..dde and its derivatives appears to act directly upon
the organism, ti:ds point-the action· on the defe�se system
of the body-needs further discussion.. The problem of the action
has been approached from various angles, and it seems to resolv.t
itself' into three main issues: (1) Do these drugs act on the
org�nisms simply as chemical disinfectants'l

(2) Do they exert

a stimula.ting eet·�ct upon the natural body defense mechanisms?
(3) Is their activity the resul.t ot a combination of these two
ef'.tects?
The theories that have been proposed to -answer these
questions may also be divided into three maln groups& (l)·that
the drugs have• stimulating ,action on the specific and non
specit"ic body daf'enses; (2) that the drugs neutralize toxic
bacterial products; and ( 5) tbat the drugs act on the bacteria
themselves, either as germicides or in some way to prevent
inv.asive power or ,ability or the organisms to multiply ..
The £irst group of theories center themselves around the
bl.ood, aoo more specifically the antibodies and the problem of
pha.gocytosis by the leukocytes. Early in the investigations,
Mellon expressed, :"The £requentl.y observed lack of the drugs 1
bacterlostatic action ....n vitro, in contrast to their effective
ness in vivo, suggested the exp.la.nation that their action might

-16-

--be -associated with the presence

or

the blood• (B-7) � Schnitker

f'ound that when tested in-a 50 per cent normal horse serum brotn,
a concentr.ation o£ 'sulf'a.niJ.a,a.ide showed lil&I'ked bacturiostatic
action, whereas his experiments in plain broth r�quired much
higher concentrations (B-6),. Mellon l&ter in his book_ says,
"that the blocp serum has its normal inhibiting and killing
power £or stre9tococci enormoLlSly enhanced,

&1ld

this by rel-

-&tivel3 minute concentr-ations of the drug in the blood• (a...;7) •

.As -.a resul.t, it oan be seen that the bl.ood is the :active vehicie

in

the c;,urying

ot

the drug to tbe bacteria. These timin&s

� the basis tor :&d,-ancing the tbeories of enhancemeJJ:1;; - of
!

�gocytosia

;Gd

-anti-toxin '8..Ction.

Somewhere in the earl.y liter.ature on the -action of the
s�OJ'.Mlroide drugs there was proposed the theory that the e.ction
I

,

... due to the stimulation ot the body clet"ences, e. i• anti....
bclJdies and phagocytoais. There has not been very much written
�I the affirmative eide, but quite a bit 9n-the negative aide
has been Finted .. The observation that whole human blood is
more oa.ctericidal. than blood from which 80% ot the leukocytea
have been removed, but containing the same concentration of
auleanilamide (lil0,000) led to the suggestion that the leukocyw
enhanced the killing action of the drug, &Di vioa

�Nii

(B-7).

•Just how s�e enhances plagocytoaia 1$ not clear,
O\U' results brief.'ly reported � suggest- . that sulf'en1 lami4e

but .
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or a serum-sulranilamide comJ;llex acts a.s an opeonin", is the
report of Fenk:elstein (18). Tunnicliff agrees with the phago
cytic theory �s a result of his experiments with the cocci
groups, stating that the drug stimul.a.tes the activity of leuko
cytes, but does not act as opsonin (76)., .Alyea admits that there
is.a possibility that the drug may increase th1;; phagocytic
power of too white cells (2) ..
Because this suggestion h&.s been advanced, it must bb dealt
with so as to locate ,as accurately as possible the action of
sulf.anila.mide,. In the large, the majority of the materi.al
printed has been in the nature of proving that such is not the
explanation of the action of the drugs. "The probabl.e exp-1,ana...
tion, however, is that sulf'anil.am.i.de in concentrated soiutions,
like so many non�specitic comouods is somewhat toxic for leuko
cytes.as well as bacteria but in dilute solutions is toxic only
£or the organisms.. Such an explanation wou.ld iniicate that the
ef£ect of sulf'anilamide on phagocytosis is not a fundamental
one and therefore does not explain its mode o£ aotionn , is the
opinion expressed by Chandler (15). Ballenger is of the opinion
that the drug holds the organism in check until the body defences
are ,able to conquer the disease (�).. t1In th� cUl'rent literatUJ'a
one £1Dds some indirect evidence which might .tend to support
the concept that su.ltanilamide .acts through promotion

at

plago

cytosis •nd stimulation ot body immunity. That pbagocytosia .
'

\.,_.,,:.

. !
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does not ex.plain adequately the phenomenon is evident from the
t'act that normal serum, from which the leukocytes· have been
removed, is »st .as et£ective a vehicle .as whole blood f'or the
action of su.U'.anilulide on streptococci•, concludes Schnitker
in his ev.aluation

at

the problem (B-6). This statement counters

the pu'bli�hing of earlier writers.
Mellon counters this.theory o£ pbagocytosis by saying,
•�though our experiments do not conclusively rule out a. direct
effect of the drug on phagocytic mobilization, there 1a notbini
in them to indicate that it occurs, In f';act, there is no c�

,.l.lini

reason £or iavoking it, because the ur;questionable

bacteriostatic effect of the drug in vivo is probably sutticient
to redicate • cessation in the production of negativel7 chemo
tactic substances by the organisms; and this in itself may be
considered a decisive £actor in the mobilisation

ot

the

phagocytes r The cell dominant in the proces�. appears to be
determined. in f'act by the degree of virulence and the-a.s04µ,at.ecl
cbemioalattributes

or

the strain in question• (B-7)4 .He had

uso £own that sulf'.an:Ji.mide t�py did not alter the qualita
tive character of the cell or tissue response to the •· strepto
coccua (B-7}. Mellon;anp his cQ-Work:ers conclude, •The weight
o:t evidence :at present does not

SUP})Ort

the view that the drua

baa .a direct inf'luence on the ao'biliaat.ion or increafe<i proclue�ion
� either type ot pllagocyte •t their source. Nor ia :tbere
£or
avul�e
.coneluaive
.
- ite st:i.mulation
'

or

ex
the pbag�.io.ild
'
.

of individual. l.eukocyte, once it is mobilized at the site ot
injury., It seems reasonably clear however, that the drug in
no� inJur&s the phagocytes so .as to prevent their ingestion
ot. suece.Ptible micro-organisms'• (B-7) .. · Professor F. P. Gay,·
in a personal communication to Mellon summarized the resul.ts
or his work by stating, "sullanilamide apparent11 produces•
bacteriostasis sufficiently marked to protect the •ccumulated
leukocytes -and to allow the na:tun.l defense macrophages to
'8.ccumulate.. There is direct evidence that t.be d�ug does not

in itself' staw.te the mopili&ation of the acro:pbages• (B-7).
�tis of the opinion that,.in the a..se of pneumon:a,

up to the crisis sul.t•p,r4dina produces a. rapid decrease :in
1-llltocytes
(1)., Britton took white blood counts Zrom 50 pa�ta
.
i

um.er sulh.nllamicie ther.pyand graphed his results e.s follows: (9)
8000
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hODt.
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Z,,

LE

t _

to

it will be seen that he tollPi a mild leucope�ia to l;Je.

-. -:-,

I

Sttliying the reticulo-endothelial system, ·which includes
the phagocytic cells, �one came to .the conclusion, •Sultanilam:Jde
therapy does not alter the cytol.ogic response to intection in
exj*rimentu. ,animals"' (45}. McIntosh al.so concl.udes that the
drug does not act -as a simple l.eukocytic stimulent (46h
the same opinion is Whitby (80).

or·

Bush also· studied the reticulo-,

endothelial system and f'ound that Uie drug does not alter the
leukocyte pattern of the b1ood or ot�r tissues,

,,.
I

•

:am that. the

drug .acted solely to inhibit the growth of the micro...orp.nisms (lit} ..
In usi.Jl& the bl.ood ot patients taking sul:t•Pfl'i4i•,

ifI··.-·:. ;

I �0

Pleming concludes tbat the ettieiencyof the l.ellkocytes is uot
inCN&sed (20)., By doin& blood counts on patients re oeivinc tQS·
drug, Bigler .found that there wa.s not produced .an� in
the total leukocytea or in the proportion

ot

•.L

the polymorpho-

nucle&r cells (5)., •It seems unlike}¥ from these experiunta
i;bat the ther--.�utic &ction ot these drugs is dwt to ..an inoreaaed
chemot.ropism

ot

�ucl.ear leukoeytes•, is expresaecl

111·

C.an (l.6) .. The weight of evidence, thus, is apinst a atia\wr
latiDg or mobilizing effect on the leukocytes.
SchnitQJ:' 1 s concl.usion&s regards pha.&ocytoeis is, •SUlt.a
n:ilam:ide does not. stimulate the defense mechanisms o£ the
in

.any

hos't

appreciable degree ..._. • .,In £.act experiaumts imi.oate that

\be sulf,&n1Jamide COlllJO•� are F&Ctioally uaele iis 1D those
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other words the sull..anilrunide inhibits the growth of organisms
and prevents overwhelming intoxication until the defense mechan
ism of the body; immunity, can be mobilized and finally bring
about recovery (B-6). Dr., Gunderson, be.fore a faculty meeting,
stated that sulfanil.l:mide does not arouse a specific response
on the part

or

the host, and that there is no direct ef'fect on

phe.gocytic activity (77) ..
Although there has been no :authors -advancing the idea that
antibodies were stimulated through the use

or

the sulfonamide

·drugs, several authors have investigated this possibility.
l

McIntosh reports that the drugs have no stimulating action on
the body defenses, nor does such administration .affect the
quality, quantity or speed o£ production of recognized specitie
,antibodies (46); Spink is

or

the same opinion (B-4} ,

The f'oregoing statemeds have dealt with the problem of ;a�
stimulating effect or the sulfonamide drugs on the body defences.
There -ere a £ew men who have advanced. am supported this theory,
�nd these were in the early days a£ the drug' a history.. We
find, however, that the preponderance of evidence is ot a-�g
ative nature. There has been found to be .actuall7 a leucopenia
during the use of the drug. Most of the writer suggest that
adverse conditions :are decreased and this permits the leukocytes
to tultill their function normally. Thus, the weight ot. the
evidence is .a-inst the stimulation. of the body defenses, either
,

'by pbagocytosis or ,antibodies, and this possibility- is ruled out.,
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ACTION ON BACTERIAL TOXINS

i�

In examining the action of every drug used in medical
practice it is logical to investigate
three possib ilities-
�
.
stimulation o£ body def'enses, action .ag inst t.tle bacteri.al
toxic products, and act;ion directly on the bacte:ri.al toxic.
products, and action directly on the bacteria itself. Attention
is now turned to the second o£ these problems.

sim.plicity in handling, tll

or

For the sake

th� various toxins will

or

be

considered •s ,a unit.
During the time that Doma.gk was experimenting in Germany,
word ot· his experiments was obtained
··:---,,

by

some of the other

scientists, Levaditi aIXl Vaisman a.re reported by Goss to have
announced in 1935 that they found that prontosil'8.ppeared to
limit streptococcal hemol.ysis and leukocidin; thus concluding
that certain sulfonamide compourxis exert an antitoxin .action
(24)., This idea has been f'ollowed by Osgood, who is its main
proponent in this country. .ls the resuLts of nis experiments,
he reports, •The major action of sulfanilamide on the beta
haemolytic streptococcus seems to be neutr�lization of the
toxins .. Either beoa.µse o£ this action, or incidentally, it also
decreases'the rate of cell divis�on o£ these organisms.

It

ap:vea'rs not to kill these organisms directly, although it does
permit the bactericida ... properties o£ human serum and to some
extent phagocytosis by leukocytes to kill organisms which they
otherwise would be unable to kill* It has no direct effect on

phagocytosis·" ( 62); he continues to the effect tba t the increased
· phagocytosis

is due to the neutralization of the bacterial

toxins by su.lf'anilamide and that the drug has no direct effect
on

either the l.eukocytes or bacteria {ibid). .After having

been severely criticized for his report, Osgood returns with,
·"We -are

still at the opi�ion that the major factor o£ sult•nil

&iilide is on the

tocins or aggressins• ( 63) •

.Although Osgood ravors the :action onthe toxins themselves,
other workers believe

the toxins;

this

the action to be on the production of

idea ties up to some degree with the .action

dlrectly on the cell, to be treated. in the next section. Gay
concludes that the action is upon the coccus not on1y by�
I
l.

iting growth, but by a temporary inhibition

ot

b.emotoxin forma

tion; the drug does not neutr.alize hemotoxin already f'ormed (25),
The experiments<;)£

Bayl.iss, "lead one to believe that the only

manner in which the toxicity of staphyl.ococci is .affected is
by an inpibiition of growth of' the organism

with a consequent

decra..se production o£ toxin• (4) - Bush -also believes that
there is .an inhibition

or

the

production of toxins since test

-.aniilials are not . protected t;#rom tht: toxins of various bacteria
in which

the drug is ef'£ective by the use of the drug (12).

King does not

believe that the toxin production is dire�tl.y

..rfected,·.basing his opinion on the !&ct that it the drug

neutr.al.iaed hemolysis o:r reduced the formation of hemol7sin
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out of proportion to the reduction

in

the numbers of organisms,

the h�molytic index of experimental colonies would be lov1er.
He did not find this to be the case, a.nd concludes t�t such a
reduction in hemolysis as is observed is secondary to the
bacteriostatic effect of the drug (56). Schnitker believes,
"The experimental evidtmce .avail.able at the presi;::nt time does

1

not appear to be sufficient to conclude that an inhibition of
toxin formation could

be

the adjunct f8.ctor supplied by su1£.a

nilan1ide in the anti-bacterial mechanisms observed in its chinica.l
use• (B-6). Osgood likewise does not believe that there is an
.a.f';tect on the toxin-pt"oducing :ability o£ the bacteria {6�).
Inspite of his opinion in one articl.e, Osgood reports in
another artilele that suli"ani�de does not inactivate in vitro
significant -amounts of hemotoxins of the beta hamolytic streP
tococci 1a.Dd others; and says that the sulf'anil.amide ther..apy did
not significantly at£ec� the course of int�tio;n in guinea
pigs (64), When testing ha:mo1ytic streptococci on blood .agar
plates, Kem:v could f'im no dirt"erence in the -anti-hemolytic
effect of the co.ntrol and sulf'anilamide plates (55). He also
found that injections of streptococcal toxins plus sulfa.nilamide
(l:1000) used in the Dick tests, showed no ditference from the
·controls; since antitoxins neutral.ize toxins, he concluded there
•s no .antd.toxin effect (55),, By using the Shwartzman phenon,.....
enon, Schneierson f'o'UJld that the sulf'onamide drugs ha.ve no
effect on the in vivo action of the toxins already formed-betQ%'-;1

cell death (69)., Buntington r s experiments showed that, •Sulfa...

•

nil&mide produced .a slight•dela,y in hemol.ysis in blood-broth

cul.ture of hanolytic streptococci., This effect was probably

.attributable. to modii'ic&tion of the· growth""'°urve. When used in
concentr.ations equal to or greater tnan that induced in the

body f'luids.ther&peutieally, sul.f.anilamide waa without,.pparent
effect upon tibrinol.ysis or formation of erythrogenic toxin

ot

in vitro, and n.s una.ble to inactivate small .amounts

toxin•

(30) .. In criticiaing Osgood, Helmnens states, •the •uthor•s
results do not suPPQrt their concl.uaions that the pri.JD.nr•ctioa

. ot

sulf'anila:mid• is ..a neu,t:.N.l:iaation

the be-ta etnptocoecus•
.

in the �iae

or

ot

°*" �

tC>rln in the

{ts),. ling believes that the reciuc�- ··
.

the hemoJ.Ttic zone on culture plates is di.18 to

the baeterioatasis which causes ,a reduction in the s:L.not-tbe

colony (S6)., •There is no e"rl.dence that the drug neut.Nl�••

bemo�sin or reduces its formation beyond what oan-1- -account.�

tor on the baaia. o£ .a reduced number of organiam& involftd.1' Cild4)* ·
I

•

•

· In working on mastitis, Bauer

•

•

.no: Gum.erson

'

•

conclude tha:\i, •the

c1rug·, s role is one pri.:maril1" of bacteriosta.sis, .allowing ·tbe
bodily defense mechanisms

to

catch up with the invader•" (77).

The -.i-Uer uperiments show that with the use of the

sulto,a.mide drugs that there is ,a decz-eaae in the .uount a(

toxins frOJ11 the bacteria,, 8"er-al authors state that tbf.
action

ot

the drug is by dµ'ect .· ,antitoxin ettectt but t�t 4Y,ISO

indicate that
bacteri.&..

the phenomenon can be indirectly caused, vi:a the

However, the we�ght

or

the evidence is against the

.action being directly on the toxins from the bacteria.
reduction o£ the to.xins, however, is not denyed�

The

From this we

oa.n conclude that the drugs produce a decrease in the .amount

or

the toxins released in the body, but that this reduction is

secondary

I_

to the primary e££ect of' bacteriostasis on the bacteria ..
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ACTION DIRECTLY ON THE BAC1'1:J:U.A.
{

I.. CHEi.USTRY

The third possibility of' the action of the sulfonamide dt-ugs
in the treatment of diseases is the action of the drugs on the
bacteria themselves. First will be presented the chemistry of
the drug, and then the various theories which have as part

ot

their expianation the chemistry of sulfanilamide.
The .axo dye, .known as prontosil, has the following struct
ural. formula:

*Most investig.tors now .,agree that the activity of the

·UO

compounds is not directly associated with the azo structure, but
with the paI11L-o&minobenzene-eulfonamide•, asserte Mellon (B-7) ,,
. Jls bas been mentioned, the dye is broken down in the body and
the .active jll'incipal. is p,,,,,aminopbenzene-sulfoDamide, which has
the following f'ormula:

Since it is known that the benzene ring is not of therapeutic
importance in the body, it" must be the radicals which are attached
to i�he amino and t� sul.f'onamide groups. Various investi
gators;:, :have .attempted to determ!Jle to which group should be,

.1
j
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.attached t:i:lenpeutic importance, am to ex.i.lain the action of
_the drug on the basis of the chemical radical involved. ·
The sulfur of the sulfonamide group has been replaced by
such elements •s e.rseni<::, carbon am phosphorus and the compounds
.found to

be

therapeutically active.

Hence, conclude Rosental

and Bauer, the sulfur. is not essential
to activity against
.
bacterial invasion; "'however, it is true that the only compounds
used to any extent, or which have demonstrated outstanding
ther.apeutic value, do retain the sulfur in the sulf'one group,
para to the udno group" (50). Thus the sulfur is not -absolutel.y
essential, but is relatively important. Maher states, :t1The
.amino group ,aDd the sulf.mido group ,;mus1; ;be:_ ln :_the:�c'J)llr&f
position on the benzene ring-par.allel compounds with these
groups in the meta or ortho positions have shown little or no
activity therapeutically• (50). Marshall has touoo that, "little
or no activity is t'ound in mononuclear compounds in which eithar
the -amino grou!,) is replaced by some other group or the sulf�na.:llid.e
!

.

group by groups not yielding -a sulfonic acid on exidation •• � •• �
I
a shift of the amino group to th� ortho or met:a position reekits
in loss o:f activity; also a thir<;i group in the benzene ring

·1

!

results in loss or lowering of activity" (54). He, however ,

I

1

concludes, "the sulfonamide group is not necessary £or actiV!1

ity• {54} .. On the other side, Mellon and his co-workers believe
that the investig.ations o:f more recent date appear to connect
I

the activity o:f the drug i.-ith th� p&ra-linked sulfur (B-7}.

:
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Fr� these statements we find ,a gener.al agreement that the ortha
position is necessary; that the amino group is necessary; but
there is a difference

or

opinion as to the importance of the

sulfone group.
The �ino group is the most important, judging from the
.amount

or

liter-ature printed referring to this group. Mellon

is the leader

or

this set of experiments. In investigating the

behavior of the ,ara-amino-benzene-sultonamide, he found the
.following.com.pounds to be formed {56}:

Reduction

<

HNH

0<
SH

Oxi.da:tion

HNH

HNOH

·0< >0
S02
so2N�

.Ac�lation
HNCO�
S0 2

�

�0
S0

)

2�

�

1. Sultanilarnide
2. Hydrozylarn1ne deriv.ati.-e-i�rmedia.t.• oxi.dationJ
•we have .already demonstrated that this derivative
is enzyme-poisoning in its effect, being �tic
ularl.y..active against the ena:yme catalase•(56).
5., Nitroso deri'�tive-oxi.ciiud hemoglobinJ :responeible
.for the toxic s�ems, but not responsible tor
bacteriostatic :action.,
4. Reduction to thiophenol-is very toxic; shows

.!
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capability of .anzrobic reduction.

·s. JlcettJ: derivative-Cormed by action or liver;

completely inacti?le because bl.ockage of�
group prevents oxidation.

is

Spink .agrees that the ,amino group situated in the para position

of the ring is related to the ther..apeutic activity of the
compounds; the -acetylated form, formed by the substitution of
&n ac�tyl group for one of the hydrogens in the animo group,
also shOlfs the importance of the animo group for this conjugated.
form has no antibacterial activity. (B-4}. ;Another argument he
uses is that other compounds w:i,th non-sulfur-containing groups
opposite the

para-6.lll.ino

position of t�e ring also have -anti

bacterial. action (ibid). Maher writes, •Removal of the uino
group destroys the activity of sulf'anilamide, while blocking of
the group, as occurs in the conjugation, greatly lessens
thera_peutic val.ue with little reduction of toxicity" (50).,
•Recent findings on another class of compounds", writes
Mellon, •have shown that the bydro..xyl,..amino group need not
reside in the par.a position .. The sulf'ohydroxamides, which may
be devoid oC .any para substituent, but which have a peri'ormed
bydrwcyl...amino {Voup.attached to the sulf'ur atom, possesses
definite a.nti-catalase properties and correspondingl.y strone
bacteriostatic power� However, there is as yet no evidence that
the cyroxamide group can be .formed from the amide group in
vivo an:i hence in the c....se

or

sulfanilamide the the .activity

must be referred to the para-e.mino groupl' (57). Shinn found
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that experiments with para-caproylaminobenzenesulfonhydroxsmide,
which contains a hydrwcy.l.amino group located differently in the
molecw., was shown to be capable of initiating bacteriostasi.s
in broth cultures oC the pneuinococcus without the degree of .J.ag
manifest&d. by sul.fanilam:ide (82). . Shinn .also states, tiThe great
volume of cl.inie&l. am experaental work carried out with sult.a
nilamide compounds has shown that the presence of the sulfur
group is essential to their effectiveness• (71}. Maher found
that removal of the sulfonamide group leaves a highly toxic
compo�, -�nine-of no value .al.ong ther.apeutic lines (50).
'"Replacement

ot

the sulf'ona.mid.e radical by -amino, nitrll,

sulfonic .acid, arsonic acid, or carboJcy"l radicals produc� inactive
com»ounds•, is the findi� of Mellow (B-7).
The clinical observation of the lag in the action ot the
drug has been explained by several.authors, includi� Long, on
the basis of a time element in the change in the chemical
substances by oxidation.af'ter the� introduction into the
:animal organism (43}.
Studies ot the chemistry of sulf'•nilsmide thus show that
both ·the amino .and the sul.tonam�e r.a.ice.ls play a part in the

dz-Ui.
i

bacteriostatic .action of the

The uino group, by weight

ot evidence, seelll8 to be the :mor� important. The suU'onamide
I

r-11ca11a not so important, butI substitution tests •hQw that

_

it is indispensable.· The .active �tion ot ·the .a� r-adioal
1

'

I

I
1
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ap�ars to be the intermediate oxidation derivative, f'or the
l'zydroxamide radical is bacteriostatic without the lag period.
This derivative f'its in with both the peptone and enzyme theory
of action.

The lag is explained on the time consumed in the
I

oxidizing of the -amino radical... The sulfonamide :Il&dioal appears
to play an important part in a.narobic bacteriostasis.

)
''-.._../

_,ACTION DIRECTLY ON 'filli BA.CTKRLl
II. PE:PTONE THEORY
tevaditi was the f'irst to put f'orth the supposition that
in some way the sulf'anila.mide attached itself' to the host's
protein, .and in this manner remered the host unfit as nutritiv$
material for the inv..ding bacteria; this action, he explained,
caused an arrest ot' bacterial multiplication, or by a blocking

or

I

oapsulogenic potential••. The other possibilities which

he suggested have been previously mentioned (B-7).
Early in the days

or

sulfanih.mide, it was observed. that

or

the drug was not effective in case of l.ocal.ized sites

such &s an .abscess. It was also f'ound that f'or this type

inf'ection,

ot

infection to be cleared up that drainage must be instituted ..and
.all necrotic tissue possibl.e to be removed. Lockwood started
his investigations after having made this observation, "t�
presence of debris, human or bacterial, diminished thei effect
I

iveness of sulf•njlamide on the hamolytic streptococc�s. In
each instance the org&nism remaining in broken down ti�sue .
maintained their virul.e.nce• (41.). One of his earl.y ex1,.ri•

I

ments in vitro showed that in large inocuJ.a, peptone •• produced by the death of some of the bacteria; thus he postulated
that possibly the more resistant survivors gain pepton� in this
manner (40). One of' L""Ckwoods later postulates was that the
mode or action of su.lf'a.nilamide was either by acting o� substrate
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to prevent the action of proteases, or by interfering with
activity of enzymes (40). · .Another iffvitro experiment showed,
"The addition ot· small amounts of peptone to the serwu yields
a nedium suitable for the active logarithmic multiplication of
young

streptococci. ,.A.t the

same

time, th� presence of peptone

tends to prevent su.lfanilrunide from exercising the full effect
of which it is capable in peptone-free serum• (40}. He suggested
that sult'anila.mide prevents specialized metabolic cactivity

by

prevention of the utilization of the protein substrate by the
organisms (ibid). The addition of peptone to serum deficient
in nitrogen which is easily assinti.lable by bacteria, bel.ieves
Lockwood, supplies such&n excess oi� nitrogenous material that
the bacteriostatic action of suli'anilaruide is to -a large degree
inhibited (42) ., Other fi:ooings by Lockwood led him to say,.
11

Normal human serum does contain minute quanitities of free

amino aci.ds and other derivatives at protein catabolism.
Since the organisms ths.t are know to be susceptible to sulf'a
nilamide are not, in general, actively proteolytic, it is
reasonable to suppose that when they are inoculated into blood
serum they depend at least in part on obtaining assimilable
nitrogen from protein metabolism rrom previously hydrolyaed
protein. Since the concentration of such free. amino nitroien
is rarely high, it is obvious that the addition of very small
traces of pegtone may markedly al.ter the amount of .assimilable
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nitrogen and thus signifioant1y improve the status of the
serum �s a culture medium for non-proteolytic organisms, such
as the hauolytic streptococcus. The'.fact that ef'f'ective
sulf'anilamide •ction depen:ls on the exclusion of added peptone
suggests immediately that the drug must act in some way through
interference with the ability of the bacteria to utilize the
tr.aces ot· assimilable nitrogen" (42). From the work or LockWood,
we find that it is thought that sulfanilamide inter£ers with
the metabolism of the bacteria; and that the -addition of peptone
supplies an excess of .assimilable n.Ltrogenous material, thus
nu.l.lit"ying the bacteriostatic action o£ the drug.
J..bout 1958, Marshall, :a co-worker of Lock.wood, noticed
that the pres�nce oC a small .amount o£ peptone, prepared by
enzymatic digestion of casein or lean meat, would significantly
diminish the bacteriostatic affect o£ su.lfanilamide ?n baolytic
streptococci in hum.n serum (B-1} .. It is this type

ot

protein

that is commonly used in the bacteriol.ogy laboratory to supp1y
readily c&v.ailable nitrogen to types of bacteria which are not
equipped with-active proteolytic enzymes with which to convert
complex Fotein into utilizable amino acids; e.g., ha,molytic
. streptococci, Marehal.l evaluates this phenomenon as evidence
that sultanilamide tends to prevent the carrying out ot some

nutritive process essential to bacteria, conjecturing that

peptone -contains some petf�ed element which is essential to
bacterial. growth, the utilization of which is_ blocked by sult•-

nilamide (B-1) ..
Before following out the indications of Lockwood and

the .timings of concurrent workers should

be

Mar�hall.,

mentioned so as to

dove-tail all of the works. Spink' s conclu;s.ions trom his exper
iments coincide with those of Locbood, viz., peptone interferes with the bacteriostatic .action oC sulfa.nil.amide {75)(72}.
He states.that in,abscesses, peptone-like substances are formed
.a.s .a result of the brealaiown of protein material (75).

Schnitker

fourn that the normal bacteriostatic -action ot human blood
serum was nullified by the addition of small amounts ot peptone,,
r

,

Working

on

l

.

the £iming of Bainbridge-that some spec�,

or

bacteria

are unable to break down protein molecules to obtain essential
nitrogen.....Schnitker conJectured that sulf'anilamide interfercts
with the f'ood suppl.y of the organisms, and that an excess of
protein nulli£ied the action of the drug (�}. The report fr03
ling sta:t.es, "i.Je have fQu?Jd that the presence o£

,a

small f'rae;-

ment of tissue in the tissue cultur� greatl.y .antaeoni.eea the
ettects of sult.a.nilamide even at a considerable dist.a.pee from
the i'ragment .., ....... ..We believe that the products of tissue
disintegration exercise .a protective et.feet on the org.ani.sms•
{56),

The clinical observ.ations of Longcope was that the admin

istn.tion of even capuativelt 1-rge uounts of sulfanilaJ1ti.de
.

i
I

.

t:aµed always to eli!Jlinate hamolytic streptococci from pe.rsiat-

. ·'
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ent cam latent infections of the tonsils (44). MacLeod f'ound
that sterile pleural efi'usions f'rom two patients with acute
lobar pneumon:i.a showed the pres�nce of inhibition of the drug,
but s'krile blood serum f'rom sixteen patients oa.use no inh.ibi-.
tion of the bacteriostatic etf'ect (49).
Following up his clinical observations, MacLeod turned to
the laboratory. He tested a num.ber of peptones too f'ourid the
presence of sulfaoilaroi.cie inhibitor in all oasea. These
peptones were obtained by the_enaymatic digestion of casein.
He f'ound, however, that the lzydrol.ysates of casein prepared
by heating with concentrated acid or alkali were entirely free
of inhibitor.- He thus concluded that sulfanilamide inhibitor
does not depend upon the presence of easily 11s_similable nitro
gen since the ,acid . aJld alkaline hydrolysates of casein supply
a srea.t excess of nitrogenous substances and yet care entirely
free

or

sulf'anilamide�inhibiting acUon (49). In tt,sting

purul.ent exudates, he i'ound the presence of relatively large
amounts of sulf'anil.amide inhibitor; •The presence of sulfanil
am.ide inhibitor in.purulent e.xudates is not unexpected, since
uoier these conditions considerable .autolysis occ-urs, al.Id

&8

shown previously in the case of normal tissues, the amount ot
inhibitor increases greatly during the autolytic process" (49) •
.After having found the presenQe of' the inhibitor, MacLeod goes
no further in .any explanation of the nature of the substance
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other than to say that it is something other than the easily
�ssimilable nitrogen which had been suggested by previous
workers., Bliss has followed up this inhibitor idea a little
further, and found the inhibiting properties, as shown by Lock
wood, art shared by casein hydrolysates and certain combination

or

amino a,cids { 6)

p

,J�ter testing e�ch essential. amino acid,

Bliss £owxi that it was methionine that conststantly counter
acted the effect or su.ltanilamide (6). He concludes that
methionine is not bacteriostatic, but is probaCly the precursor
of the substance which has ,antisulfanile.mide activity { 6) *
.Atter studying the, structure

or

para....a.mino benzene suli,"on

,amide, Selbie experimented with par.a-aminobenzoic ,acid and f'ounl
that it wow.d inhi'bit the therapeutic action of sultanilamide
{68) .. Lalldy .found, "The bacteriostatic effect, as measured in
vitro, of sulfanilamide, sultapyridine, and. sulf'e.thiazole on
:�

streptococci, pneumococci,-ihd staphylococci respectively, has
been found to be completel.y,neutraiized by p-e.minobenzoi� acid.
This observation suggests that this neutralization mechanism
is similar for any of the organisms and inhibitors investigated•
(57) ,, Par,a.....aminobenzoic -acid is essential tor the growth ot
the micr0:-0rganisms. Howe�e:r, Woods f'ound that this product is
normally synthesized in sufficient quantity by the streptoco.cc� ..
On the �bove bases, he suggested that •the enzyme reaction
invoived in the further utilusation

or

p-iuiinobenzoic acid is

subject to comparative inhibition by sulfanilamide, and that
this inhibition is due to a structural rele.tionship between
sulf'a.nilamide .nd p-aminobenzoic acid• (81). Fildes ., a co-worker
oC Woods, suggests that the action of sulfanilamide is competi
tionf'or an enzyme, associated with an essential metabolite,
and that this essential. metabolite: is p-aminobenzoic acid (17}.
MacLeod confirmed. the observation of Woods -and Fildes on the
•nnulling e£fect oC �nobenzoic acid on the bacteriostatic
action

or

the sull'anilamjde drugs, but states that the inhibi

tors present in his en£ymatic digest of casein differ in
certain of their chemical properties f'rom p-aminobenzoic acid
b

(49), .Lockwood has stated that p-e.mino enzoic acid is an
essential. intermediary metabolite f'or bacterial cells; that the
cells can synthesize this f'rom the primary essential amino
acids or obtain it f'rom the environment; sulfanilamide is
chemioalJ.y close to the p-e.min�benzoic acid ani competes with
it £or molecular groupings on

t;he

bacterial protoplasm.

Thus,

f
he stated, the metabolism oft� cell is inter:erred
with The

�o�nz�ic acid comes .from tt;he degenerating tissues (.B..-1).
Lockwood continues, "'There is

no

direct evidence that the

inhibitory affect ot pept.one a.I1(l of other proteolytic products

is due entir,.,l.y to their content at p-e.minobenzoic acid or ol
I
some structurally related material. However, there ls such cloa:J
similarity in the nature of the antisulf'anilamide effects of
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these substances as to suggest that the same mechanism accounts
for the sulfonamide-inhibiting properties of' proteolytic.
products;w (B-1).
Briefly, then we have traced the investig�tions of the
anti-sult':anilamide activity from the beginning with peptone,
to the theory of the essential..amino acids, specil'ical.ly methio
nine, to the latest theory of' p-,e.minobenzoic acid- Most of
the investigators f'ollOllfing .along the line of' Lockwood all seem
to1coneent that the p�nobanzoic acid is the actual anti

sulf:anile.mide compound for which they he.� 'been searching. The

nut question �s just how does this acid function in tl:le 'bacter

iostatic action of' the sulfonamide drugs. Even bef'ore his

"T · ···.

peptone idea was thoroughly under

way,

w

Lock ood concluded fros

some of his experiments that, •Indirect evidence is ottered to
suggest that sultanilamide.acts upon hmmolytic streptococci
by interference with their protein...digesting mechanism (39).
Bush states that the works of Lockwood, arid. Spink indicate,
*that the drug int111r£ered. in some way- with the ability

ot

the

enzymes of the micro-organisms to digest proteina• (12). Stamp
suggested thal.t the anti-sulf'.-nil.amide £raction may contain&n
essential. amino acid, or could be ,an essential part.a£ the
enayme system .affected by the drugs {75}. Neter ia o£ the
opinion that the latest.work with the drug illiio&tes that the
cetion �. the drug is one c4, •competition with bacteri.al

·-� .

f-·

.

•"'-,./·

. ·. :j
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enzyme systems associated with essential tnetabolites" {61).
1

From these findings, we can conclude that, according to
thi�the pres�nce of p-4i.!Ilinobenzoic aeid, or a precursor, is
f'ound in the presence of protein ca.tabolism. 'I1his substance
is expec:ially plentiful. in localized collections of cellular
destruction. Because of the chemical preponderance of this
substance it is able to combine with the cell in some manner in
larger molecular numbers than a.re the sulf'onamide drugs, and
thus able to exert an anti-su.i.fanilb.ill.ide action.

Thus it is

concluded that the action a£ sulfanil.amide and its deriv�tives
is one of interfering with the protein metabolism ot the cell.
Many are the suggestions that this action is actually due to
an effect on the enzyme system of the bacterial. cell.
However, this theory does not expla.in or contain all ot
the £indings, and the negative side must �lso

be

presented.

Long states that the drug may act either on the bacteria to
prevent them from utilizing the substrate, or by altering the
substrate so as to render it unavailable to the micro-organism
{B-o}. His thwory wil.l be taken up in the next section. ?he
investigations

or

Lockwood have been along the linBs of growth

promoting substances; Long states that the addition of extrose,
which is a1so a growth stimulant, showed no decrease in the
bacteriosta.tic action

or

su.lfanilamide (B-5),, Long concludes

that, RJ..s concerns the theory of Lev.aditi and Lockwood, it seems
0
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that between the proteolytic power

or

virulent and avirulent

streptococci, it shoui.d be regarded only as an interesting
spt;cu.lation• (B-5)., Weld states, •Our experiments do not seem
to support the theory that sulfani1£amide intert·eres with the
power of streptococci to utilize serum proteins or that peptone

per se interferes specitically with the lactericidal effective
ness of sulf'.anilamide• (79}. Kalmanson could find no ef'tect
of peptone in his experiments (5l.) .. Long found that in the
presence

or

beet infusion brotb..:or 50 per cent normal horse

serum broth that the Jr4U11inobenzene sulfonamide still had a
f

i

t

Jll.\rked baoteriostattc .action on beta hanolytic streptococci
(43).., Gay states, •Too sweeping. conclusions have hitherto been
drawn from the study of a single var:iable factor, such .as an
unfavorable temperature or the absence or presence of peptone•
(25). It must be talcen into consideration, nevertheless, that
the nE;g.ta.tive views that have been written were all aimed ._t
the f inliings of Lockwood and his peptone t"indings, and not at
the :findings whichfoUowed the beginning work of Lockwood and
nis co-investigators, viz., p-,aminobenzoic acid am enzyme effeot*
The recent timings of the Lockwood group with the wealth of
investigations, am ca.re in the work done cannot be dismissed
so lightly�
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.ACTION DIRECTLY ON THE BACTli..RIA
III .. CATALASli: AND Ei�ZYME
The first investigations al.ong the line o£ emymatic
activity of suli'anil&mide was maa.e by Meyer, a Frenchamn who
f'ound th&.t an intermediate oxidation product of the amino
group, the hydroxyl.amine (NHOH} derivative of sul.tanile.mide
wa� highly active in the test tube against streptococci.
Meyer postulated the slow f'ormation in the body of tnis deriva
tive as the basis for the activity o£ suli'anilamid.e (65).
Shaffer states t�t sul.f'ann.amjde activity is not possible
without the presence o£ oxygen (69} r ..Among the. ear1y invest{.

I

ga.tions was one by Keilin, an Eng1ishman, who :found that the 1
.

decomposition

or

I
I
I

hydrogen peroxide is brought about by success-

ive reduction of the oatalase iron by the peroxide.

He found

among the inktj.bitors of the oataasa to by hyo.ro;xylamine which
inhibits the reox.id.&tion

or

the reduced cata:i.ase by molecular

oxygen {54)r

Mellon is the leading investigator in.the United States
r
of' the catalase theory.. The anti-catlil.se activit of hydro�l,

amine had already been pointed out. Taking the f'indings of

i
bacteria
af'!'ected
by
the
\
meyer plus the observation that the

drug were mrobic, he started investigating the oxidation
eulf'anil.amide ., Mellon .found that, ttoxidation o£ the type
produced by ultr•violet acting on -aqueous solution endows

or
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sulf'anilam.ide with marked anti-ca.ts.lase pro�erties.

It there-�

f'or·e av1ears reasonable tc select· the i":Lrst step of' . oxidation,
that is, the hyroxylamide: o.erivative, as the seat of activity"
(57) ..

(See section on chemistry.) Mellon pictures the conver

sion of' sulfa.nilamide to anti-cat.lase by the pneµmococcus as
follows:

•The .above f'igure is ill.ustrative of the changes that we picture
as taking pl.ace when sul.£anU;amid.e di:ttuses through the capsule
of the pneumococcus into the interior of the cell .. Under
norJBi.l conditions biYdrogen peroxide is being elaborated.by the
cell, btit.<is immed.iately destroyed by the enzyme catalase,
which is .a.J.ways })l'esent, in its destru�tion into water and
oxygen.. However, when the sult.anilamide is converted into
anti-catalase (AC) by the oxidative processes in the cell,
dit.fusion of' the catala.se f'rom the exterior is blocked, and this
resul:t.s in the accumulation of peroxide, no:t·only in the cell,
but in the surrounding medium" (56). Thus we see that he believes
that the hyro;icylamine .M.riva.tive poisons the enzyme catalase,
.which primary !"unction is to destroy the t� hydrogen "peroxide

as soon .as it is liber.ated by the bacterium; the accumulation
or the hydrogen peroxide accounts for the bacteriostasis. {56).
Main formed the intermediar-.f oxidation derivative by t·he irrad�
iation or sulfanilamide by ultr.aviolet light, :and :found a
correlation 1:?etween the colored product produced .and the ;anti
c&tlii.se activity. He thus concluded that it was oxidation
which accounted for the •.activation• o.f the sulf'.anilamide (51).
· Main is of the opinion that by the action of an anti
oat;6se th� hydrogen pt:.roxide, • metabo1ic product, -.y reach
high enough concentl"ation �ound the organism to retard further
i

• •• �.

•

growth(�)., Mellon demonetllated with :Pmllil"JDOCoccus c�tures
containing• 10 mgm. of sulf'.an1lsmide that eydrogen }l8l'oxide did
..actually accumulate;
he tffliln
added fresh peroxide comp&N.b1.
'
.

.

1

to the con�entr.ation. which
had accum\U.ated. ' in the cultures
.
under the :µif'luence of suJ.tanilaroide .and brought about a similar
degree of bacteriostasis (56). He st.ates that his expertm.exi:t,
•indica.tes that the

uug must

be converted. into some 'ba�terio

atatic f or'1, but only .after the germs ha:ve started to grow in
.

'

it app:recdAllblf ••·o.-.-this substa.nee is ey<iroql.udne, or aoae
closely re�ted de_rivative (56). The results of locke 1 1
_experiment� .are, 11 T.be pneuaococcus -and tbe _hanolyti.c strepte>
coccus ba.v, the property of being -abl.e to produce peroxide

without,-•� the same .time, being :able to prevent accUDNlation.
- Bott.,_; -.re ,sensitive to peroxide injury am depem £or 'peroxide

..

-

--J---
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-,,_____.

elimination on catalase borr01red from the medium supporting

gro,vth.. Cata.lases decompose peroxide am permit growth so long

as they remain e.fficient. Th�are inactivated by hydroxyl

Gline .am by substances related to hydroxylamine in structure
or propertiee-1' (58). ·Locke found that,

11

blockage o£ the pal'a

amino group in sulf'.anil.am:lde, through acetylation, produces a
degree �.·impairment in effectiveness parallel to the degree

or

impairment in susceptibility to oxidation effected"', and that

more drastic oxidation to the p-nitroso is not effective (58) ..

Mellon state�, as regards his theory, •The fact that su11'anila-.

aide is capable

or

being converted by the germ itself into the

anti-cayal.ytic hydroql.amine derivative, is a most important

.tact in connection with the drug's mode of ,t.ction .. It means

that its conversion into the active form need not be brought
i

.

.about by the cells of the host, a fact which appes.rs to be of

.

i

cardinal importance owing to the great ins'ttbility of the cactive

form per se .. That is to say, if' the conver�ion to the hydrox
ylamide derivative were not capable of being made by the germ,

,

I

but only by the host cells, it would pl'obab�y be broken down

comp.lately- before enough of .it had a chancel' to reach the germ
.
I
so it could be effective• (56), In measuring the detectable

.

peroxide in control and sul.fanilamide cultures, Mellon found

that tor the first three hours the content was s&bout the sam&J
however, :after re�tlon

'--·'

or

growth was apparent in th�

.J
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sulf'anilam.i.de cultures, the amount of peroxide .accumulated
al.though the growth was becoming less than the controls. This
snowed an increasing .amount o:f peroxide per unit of bacterial
substance... Continuing .his experiment, ;af'ter a .five hour period,
he -added to the control the same concentration of peroxide •s
he had in the su.lfanilamide cultures and got the same degree
of baoteriostasis as was produced by the sulfanilami.de (57).
In studying the Eh (pc:,tentitl) o:f the cultures, Mellon fown
the elevation in the potential to

be

consistent with his fim.ings

of increased. peroxide production in the presence

or. sult.nil

ami.de; he .also found that the l.owering effect

catala.se on

or

the potential to be.opposite o:f the el.evating efi'ect of the
anti-catalytic sulfanilamide., This e1evation of the Eh is brought
about �Y the peroxide accumulation (57)., Mellon is of the

opinion, •that sulf.a.nilamide is inactive toward highly virulent

bacteria until it is partially oxidized to stages whose chemical.
properties make £or inactivation of the germ's enzyme thereby
interi'ering with their food suppl.y; an accompanying et"fect of
this starvation process is to permit the accumulations of their
own excretory products of which the toxic }:zydrogen peroxide
'is one"' (55) ., He believes that due to the action of the drug
on the bacteria, that there is a resultant phase-transformation
which brings the germ within killing range of the immuno
phagocytic dei'enses of the host (58); and that this is brough�

'---

-a.bout by the act.ion

or

the drug on catalase as well .as peroxydase,

·certain dehydrogenases, and nitratase, thus seriously affect-_
ing the nutrition of the bacteria (57) •

. The Eh (potential) of' cultur1;.:s wa� studied by Fox who
f'ound that the Eh or mrobic sultanilrunide-cultures remained
elevated much longer than control culture.a, but that when
bacteriosta.sis ceases, the Eh al.so .£ell (22).. Hewitt f'ound that
(l} addition of' catalase inhibits peroxide formation in cultures
0, hamol,Jtic streptococci, and (2) addition· of ca:tala�e to -a
culture containing peroxide causes .an immediate -and r-apid taU
in potential (29). He :al.so f'ound that the organisms are appar-.

ently not injured by the peroxide in low concentrations (ta}.

Th us we have more indirect evidence that the action

at

the

sultanilamide is one of anti-catalytic activity.. warren found
that the 84dition of sult-anilamid.e to cultures was ,accompanied
by an elevation ot the oxida:t.ion-reduction potential.J that
compounds related to sult'-.nilami.d.e but lacking in 'b&cterloatatio
action a.re without et£ect upon the culture potentials• (78}.
This f'inclilli shows that the action of the drug would aeem to 'be
h

on the bacteria, resulting in an increase of peroxide, r.ater
tl'laJ» a direct etf'ect on the catale.se.
The earl.y work of Shinn showed that there was an accumulation of eydrogen piroxide in the zoDe immediiatel.y suno�ing
.

.

the cultures (70). He .agrees that the mechanism o£ s-ulfanil.-

...__...
.amide action is in part through the inactivation of catalase
(70), but states that part

ot

the action is due to the sulfonamvio

group expecially UDder anerobic conditions {71)., In a later

experiment, he was um.ble to detect any eydrogen peroxide in
cul.tures which contained no sulf.anihmide {71.) .. Shinn states,
nunder normal. conditions the amount

or

pxygen present in plasma

is .adequate for support ot -a high degree
depe ndence

or

or

inhibition., The

sul.f.anilr.mide upon oxygen imioates the advm

bility of maintaining or increasing, where possible, the oxygen
suppl.y at the 1esion• (71.). Fox strengthened this point when
he t"ound that oxidation by simpl.e ,aez:..tion

or ,a

culture favored

oxidation aild prevented reduction (21).. Main Cound the con
centration of peroxide per uirl,t of growth

wa11

from two to ten

times greate,r in the presence of compounds which caused bacter
iostasis than in control cultures (52}., ilong with the accum
ulations of peroxide, McKinney found other evidences of dimin
ishing metabolic activity-fermentation of inulin, and. decreased
virulence (48) ., Morgulis (ot this campus) found that, •by
making the hydrogen perwtide concentration high enough, the
catala&e reaction could be practically stoppedff {59).
In doing blood oatalase determinations in 21 patients,
Clyman £oll!ld in the £ifteen patients receiving suli'ona.�ide drugs
a definite depression

ot

the blood catalase activity; while the

controls showed practioally no diminutions of blood catalase

concentr.a.tion of hydrogen peroxide is not high enoUgh, in the
sulfanilamide cultures, to .account. for the decrease of the growth
of tbtl organisms.. Long critciaes the ca.talase theory by saying
that peroxide concentr.ation should kill in a cats.lase-poor
media, but did not find this to be so; also that the henolytic
streptococ9i vary enorhlously in their ability to produce pera&id.e,
but that thare is no correlation between their production ot
peroxide and their senaLt;ivity to sultanilamide (B-3)"
The last statement by Fox ( two paragraphs bef'ore) brings
•,;

U!J the question ot enzymes in general.. .All ot the material.
presented previously bas to do with one specific enzyme
oatalase .. Lewis states that the :action of sultanilamid.e is,
•It inhibits the growth of the bacteria, probail.y by interferin.J
with their metabolic enzymes, especially the OJtidases• (B-o).
Mclinney l.ists the enzymes .r:rected o&s cata1ase, perox;ydase,
de�ogenases, .and nitratases, &s well as proteolytic ens�•
(48). Broh-lahn found that sulfanilam:i.de prevents th� oxidation
ot lactate by nitrate (10)., Lord stats,

11

0ne explanation ot

this bacteriostasis is that it is du� tn part to impairment of
the nutrition of the bacterial cell through inhibition of an
enzyme or enzymes• {B-2).
Bacteria, just like the more highly integr"9.ted species,
satisfy their nutritive requirements through the elaboration
,and. &ctivity of enzymes. This enzymatic activity involve, a
I
.\..._..,

�

,)..; ...•.,.;-- _ _ .
:: __
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series of chemical. re1wtion ta.king 9lace near or on the surf'ace
of the bacterial cell .. The bacteria ll)G.nnot grow in media which
is either deficient in any of a number of essential metabolites
or it the enzymes through which these materials a.re utilized
b�come physically or chemically inactivated.

Since the suli'ona.:aide

drugs allow the bacteria to grow for a short time and :then': rath3r
abruptly terminates the logarithmic phase of growth, it would
seem that the effect is an interruption of a.n essential nutriti�e process at a level of population much lower than that which
the medium would otherwise support. Woods bt:lieves that the
enzymatic rea.tion involved is in the synthesis of para-amino
benzoic acid by virture of its chelilical similarity to the product
of the reaction (81).

There is one question that remains, .and that is the
sel.ectivity

or

the suJ..tonamide drugs., Various species of

bacteria. hb.ve various enzymatic systen1:s .. The selectivity of
the drug for these various enzymati systems in not unusual.

We have Sb.lts, basic dyes, and acridine dyes which are all
sel.ective for various types o:f bacteria.. Broh-Kahn says that

suli"anilamide selectively inhibits only .certain mechanisms (lo}.
In summary, we aee that cultures treated with sulfanil

amide show a higher concentration of hydrogen peroxide than the
control cultures. This is due
. to the anti�catalaee activity
of the drug. There is a correlation between the action ot the
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oxidation derivative of sul.tanilsmi.de &Di the .action of sulfa. nUamide; therefore, the �ctive -agent

or

the drug is the inter

mediary oxidative derivative,· The raising of the Eh also.
points ·to the oxidation theory of t-he drug. .Animal observations
show a decrease of catalase activity under sull'anilam:l.de
therapy, The bacteria df'ected by the drug are the &3l'obes, and
it is this arobic condition which is necessary for the ef'f'icacy
of the sulfonamides. There are many concurrent observations
whieh show disturbences in the metabolic processes of the
bacteria, Many of the findings suggest that the action
drug_is directly on the enzyme system

ot

ot

the

the cell •hich results

in an indrease in the concentr.ation of the peroxide, and that
the eff'ect on the catalase is secondary to the other changea
witbin the cell.

!

.I

·-- .

. _: -:- · .......

_
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EVALUATION

or

� quick resume or the gene&l observations or the action
sulf'anilamide rev�ls that there is an action on hamolytic

streptococci resulting in a decrease in the growth r,ate, after
a lag phase, -and• protl:lction of animal.a against the infection.
This :phenomenon is brought about by bacte:d.ostaais. The drug
is effective in those infections which are airobic am or a
general.ized cbar.acter; localized areas

or

tissue necrosis

maintain the infectious !f'ocess with little hindrance from the

drug. Cultures under the inf'luence or sulf'anilandde show a
change in the phase to a less virulent form.

It has been found that blood with a given concentI,ation
of sulf'anilami.de has higher bacteriostatic po¥Jer than has broth
with an equal concentration.

It has been propoaed\by severi.l

investigators that the action of the drug ws:s to increase
pha.gocytosis. Howevlilr, the vast maj�rity

or

the investigators .

are against the theory or effect on the body defenses. Their
evicience is that there is actually a mild leucopen:La produced
•

I

with the .adniinistr.ation of the drug; the cyto1ogic response of
the reticulo-eaiothe.lial. system is not a1tered by the drugJ
the lack of immunity is not helped by the use of the sulfonamida1,
It therefore seems that the cleaning up of the bacteria is not
due to the er.teat di.re�tly on the body de.fe:qses, but rather that
by the use

or

the drug there is creati;."'<i .a situation diat"avorable

i
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to the bacteria, and t.b&t this action permits a more ef'f'ective
phagocytic activity of the body ..
Of course, this action could easily be due to the neutral
ization of the bacterial. toxins by th8 drug and thus decreasing
the to..dcity of the phagocytes.. There is f'oum a definite
decrease in the toAicity of patients wxler the medication with
the sulCona.mides. However, the evidence is strong and over
whelming against any dµ-ect action of the suJ.£onami.de drugs on
the neutrtlization
of the drug is one

or
or

the bacterial to:xins.. Again, the action
decreasing the toxin output of the baeteri&

by directly aff'ecting the bacteria.
One of the best points :for the direct action of the drug on
the bact�ria was made when McK.inl.ey said, •These neg�tive resul.ta
with sultanilamide

in

treating experimental virus infections

raise certain qubstions regarding the mode of action of this
drug ... .,...,It is suggested that sul.f'.anilamide is unable to exert
its action against the infecting agent when it has inv.ded ti.
tissue cells as in the case o£ virus infections .. The efficacy
� sultanilamide in specific bacteri.a.l. diseases may deperd
partl.y on its successful attack against extracellul.e.r organisms,
while the host cells the�elves are contributing to the defense
.against invading microbes" (47} .. The opinion

at

Marshall i.a,

•,At present, the balance qf evidence would seem to indicate tbat
sulf'tnil&.mid.e .aff'ects the invading bacteria in the sense of ·
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exerting a bacteriostatic or bactericidal action which is not

sut'£icient to effect stel'ilization without the co-operation

or the defense mechanism ot the host"' (53)., Keeter summarized.,
•sulf'.anila.mide inhibits the growth ot organisms and prevents
overwhelming intoxication until the defense m�chanism �n be
mobilized and finally bring about recoveryn (52). Further
evidence for the location or the effect being on the bacteria
is the clinical. observation that the .administration of the. ·drug
al.tt:rs the picture of blood cultures and bacterial·
typing. Roth
.
is of the opinion tbi..t since there is a long latent period before
securing -an effect with sw..Canilamide that it is doubtruJ. that
the drug directly affects the cause of' the disease (66).· However,
this objection can adequately be explained by the theories of
direct bacterial. action.
In recapitulation of the foregoing observ.ations., it seems
possible to concl.ude that sulf'anilamide does not-arouse•
specific response on the part or the host.. The producti.on of
;antibodies is not stimulated, .and there is no direct act.i.on
upon the phagocytic mechanism., The more recent investigations
pl.us the number of investig.ators gives considerable weight to
the evidence tbat the drug does act upon the micro-organisms
in v;Ltro and in vivo, Most of the workers are of the opinion

that this •ction takes the form

ot

V

or an inhibition or the growth

the bac1;eria which thereby permits the defense mechanism

,
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or the host to -accompl.ish its f'unction.

So tar the evidence

presented has ruled out the direct ef'fect on p.hagocytosis .and
the body defense13, .and it is stil1 n�cessary to find a positive
explanation for the inhibitory .action

or the drug bf dir�ct e.t'fect

on the bacteria.In studying the chemistry of sull'anilamide, it was shown
that the components are: the �nzene ring, the amino radical,
and the sulfonamide r,adical. The two must be in para positions,
not to make it bacteriostatic, but because it is the only
form that the body can band.le. The amino group ·is the more
important, but the sulfur in the sulfonamide r.adioal is aleo
essential. The possibl.e chemical f'&te of the molecule ••
ahown;__the intermediate oxidation derivative---hycirox;yl.am1na
is the f'orm that we .are most interested in ..
Relative
.

to the -action of the sulfonamides on the bacteria, .

the peptone theory was the first pre1:1ented. The background tor

this idea is that with luge inocula or with locali&ed. :Lntectiou,
I

such .as abscesses, the drug is only slightly ef'f'ective. .lt
f'irst it •s thought that peptone •s responsible for the

.

intert"erence with the .action of sulfa.nil.amide; but further work
.

indicated �t one of the essent:ial amino acids .actuall1 waa

I

involved .. This acid ws later found to be methionine, which is

veey closely rela.ted to sulf.ti.nil11mide, cbemioally. It•• d�

.{

'

,<,
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by other workers that p-aminobenzoic acid had

&

much more de:tinite

or

action in the inhibition of sulf'anilamide.- Because

the very

close chenical relationship, it is thoUght that the two compounds
compete with each other f'or groups in the bacteria protoplasm.

t

The p-e.minobenzoic acid . appears to be an essential. intermed.tary
metabolite, which is necessary for the c�lls to obtainJ it inter
feres with the ..action

or

greater than that

ot

or

the drug when its moleculs.r number is

the drug. It will

be

noticed that• number

th€ investigators have mentioned that the drug has the effect

·1

of interfering with the metabolism of the micro-orga.nisBlB, -.ncl
several. say that this efl'ect is tbroug� the enzymes.
The catal.11.se theory of action on the germ states tha.t the
intermediate oxidation product has the e:tfect
-action

or

or nullityina tb.a

the ca:t.a_.., This catal.ase .has as its f'unction · ..

the breaking down
metabol.ism

or

'

or thtt peroxide which has been formed by the
-

the cell., When this takes place, t� el,evat.84 :: . r.

concentr,ation of the peroxide causes a disturbance in the cellulla2'
'

·,

\

metabolism. The elevated Eh shows that this action is taking
place ur:der oxidative conditions.
.;a,

It was shown that there w.s

decrease in the oa.talase activity of the blood under suJ.ra-,

nil.amide ther.apy; and that the increased concentration

ot

biYdrogen peroxide would cause a be.cteriostasis in itslef.

It

will :again be noted that the majority of the worker� mention.
that other enzymes are invQlved, and state that they beline

j
J
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that the indications point toward

,a

general enzymatic action .,

H;ydrogen peroxide itself shows an anti-cat.a.lase ,activity, and

it is probable that the action is one -.using a primary greater

:i;,roduction of. the p.:roxide, am a secondary effect on the

oatalase.

Tht:l two theories, on the face, appear to be very widely

separated.- The positive finclings

in

each. case cannot be denyed .,

To correlate them seems at first impossible.· The more recent

timings in the peptone theory point to a specif',ic compound

being involved, the abumance of which will nullity the action
of the drug, but the .abundance of the drug seems to interfere

with the action of t�s p-4llllinobenzoic acid.,

In infections

locallzed,snowing a nul.l.ifying ettect, the oxygen tension 11

low •.,A lack of necrotic tissue, with its abundant nitrogenous

materieJ., is alos a condition
in which oxyien tension is high
.
,

enough to show an anti-ca't41:lase effect., The latest findings
indicate that the action is one connected wit.h a chemical

blockage of some enzyme which is necessary fo� the metabolism

. of the cell..- The cata1ase theory ·sp.ows the action of sultanilard.de
to invol.ve .a specific enzyme, or at least gives the s&.me results

as though it bad acted on· this enzyme.

However, incident&l

tindiIJgs showed that other enzymes were � �teated.

&ppears_tbat both of the tlleoriec:1 are brought together
.

It thua

f1 the
I

x
by each that the actual oftect is onerdirectq'
c,¢.nion epreosed

•
·,

,-�-

.- �-� .

......
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on the enzymes of the bacterial cell. This action is meni:f'ested
by (l} the accumulation of hydrogen peroxide, because:the
ca.ta.lase is blocked at the bacteria, and (2) the disturbed
nutrition shc,wn by changes in phase and virulence.
For the effectiveness of the drug, the bacteria affected
must be under a:z-obic conditions with onl.y e. relatively small
runount oi' necrotic tissue present.

Under these conditions the

drug produces demonstrable disturbances in aetabolism and a
increased concentration of hydrogen peroxide. These two phen

omena are caused by a cnemical blockage of the enzyme system ..
Since the effects ar� ma.nif'est only under favorable mrobie
conditions, it is pretty sai'e to speculate that the specific
enzymes are those aBsocia.ted with the respiratory system of the
bacterial cell. However, the final proof of this s;,eculation
shall. have to await further investigations of the biologicai
chemist •

.�:
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